Biotechnology Archives - RamaOnHealthcare

Pharma / Biotech: Biotechnology

Read recent healthcare news on biotechnology in healthcare. Stay current on trends with our daily newsletter. Also, research insights with our curated search portal.

Digital health companies enabling R&D topped 2021 US investment, Rock Health says

2022-01-18T22:06:51-05:00

pharmaphorum January 19, 2022

Digital health companies enabling R&D topped 2021 US investment, Rock Health says2022-01-18T22:06:51-05:00

One positive to come out of the pandemic? Improved science literacy

2022-01-19T21:46:19-05:00

Becker's Healthcare January 19, 2022

One positive to come out of the pandemic? Improved science literacy2022-01-19T21:46:19-05:00

Google develops AI-powered tool for faster disease detection

2022-01-19T20:08:11-05:00

Becker's Healthcare January 19, 2022

Google develops AI-powered tool for faster disease detection2022-01-19T20:08:11-05:00

Human Proteoform Project Could Be Biology’s Next Moonshot

2022-01-19T19:56:00-05:00

Bio-IT World January 19, 2022

Human Proteoform Project Could Be Biology’s Next Moonshot2022-01-19T19:56:00-05:00

7 Burning Questions from Life Sciences Companies on Using AI Agents

2022-01-19T19:48:17-05:00

HIT Consultant January 19, 2022

7 Burning Questions from Life Sciences Companies on Using AI Agents2022-01-19T19:48:17-05:00

Spatial Omics: The Next Wave in the Biological Research Revolution

2022-01-19T19:47:02-05:00

HIT Consultant January 19, 2022

Spatial Omics: The Next Wave in the Biological Research Revolution2022-01-19T19:47:02-05:00

05 Trends In Healthcare Industry To Watch Out This 2022

2022-01-19T17:20:13-05:00

Hospital & Healthcare Management January 19, 2022

05 Trends In Healthcare Industry To Watch Out This 20222022-01-19T17:20:13-05:00

UCB to buy Zogenix for nearly $2B in ‘first step’ for M&A in 2022

2022-01-19T16:58:25-05:00

BioPharma Dive January 19, 2022

UCB to buy Zogenix for nearly $2B in ‘first step’ for M&A in 20222022-01-19T16:58:25-05:00

Shining a Light on Rare Disease: Evidence Challenges and Solutions

2022-01-19T15:28:14-05:00

Pharmaceutical Executive January 19, 2022

Shining a Light on Rare Disease: Evidence Challenges and Solutions2022-01-19T15:28:14-05:00

The Future of Patient Safety Is in Automation, Digital Health

2022-01-19T14:56:22-05:00

Pharmacy Times January 19, 2022

The Future of Patient Safety Is in Automation, Digital Health2022-01-19T14:56:22-05:00

Regenerative med biotech ProKidney inks $825M merger to back CKD cell therapy

2022-01-18T22:08:18-05:00

MedCity News January 18, 2022

Regenerative med biotech ProKidney inks $825M merger to back CKD cell therapy2022-01-18T22:08:18-05:00

Sema4 secures a deal to acquire GeneDx, capturing $200M in private investment

2022-01-18T22:07:43-05:00

MedCity News January 18, 2022

Sema4 secures a deal to acquire GeneDx, capturing $200M in private investment2022-01-18T22:07:43-05:00

Abbott, BD, Quidel pursue DTC strategies amid ‘paradigm shift’ for at-home, self-testing

2022-01-18T21:22:58-05:00

Healthcare DIVE January 18, 2022

Abbott, BD, Quidel pursue DTC strategies amid ‘paradigm shift’ for at-home, self-testing2022-01-18T21:22:58-05:00

BioNTech and InstaDeep join forces to predict high-risk COVID variants

2022-01-18T21:20:39-05:00

Healthcare IT News January 18, 2022

BioNTech and InstaDeep join forces to predict high-risk COVID variants2022-01-18T21:20:39-05:00

Sema4 Acquires GeneDx for $623M to Strengthen AI-Driven Genomic Platform

2022-01-18T21:09:54-05:00

HIT Consultant January 18, 2022

Sema4 Acquires GeneDx for $623M to Strengthen AI-Driven Genomic Platform2022-01-18T21:09:54-05:00

Fierce JPM Week: Verily’s Lee details ‘strong’ revenue growth as company eyes employer market in 2022

2022-01-18T20:58:25-05:00

Fierce Health Payer January 18, 2022

Fierce JPM Week: Verily’s Lee details ‘strong’ revenue growth as company eyes employer market in 20222022-01-18T20:58:25-05:00

Addressing 4 Common Roadblocks When Using RWD in Regulatory Submissions

2022-01-18T17:14:45-05:00

Pharmaceutical Executive January 18, 2022

Addressing 4 Common Roadblocks When Using RWD in Regulatory Submissions2022-01-18T17:14:45-05:00

Applying AI to Real-World Data to Improve Pharmaceutical Development

2022-01-18T13:45:22-05:00

Bio-IT World January 18, 2022

Applying AI to Real-World Data to Improve Pharmaceutical Development2022-01-18T13:45:22-05:00

How CRO venture capital relationships can help biotech fundraising

2022-01-18T13:43:58-05:00

BioPharma Dive January 18, 2022

How CRO venture capital relationships can help biotech fundraising2022-01-18T13:43:58-05:00

Opinion: Is it time for big biopharma companies to rethink the use of federal funding for R&D?

2022-01-18T12:57:35-05:00

STAT January 18, 2022

Opinion: Is it time for big biopharma companies to rethink the use of federal funding for R&D?2022-01-18T12:57:35-05:00

Precision Medicine, Omics, and the Black Box

2022-01-17T18:15:43-05:00

Mayo Clinic January 17, 2022

Precision Medicine, Omics, and the Black Box2022-01-17T18:15:43-05:00

Decentralised trials: beyond the pandemic

2022-01-17T16:53:12-05:00

pharmaphorum January 17, 2022

Decentralised trials: beyond the pandemic2022-01-17T16:53:12-05:00

Understanding the Purpose of Biomedicine

2022-01-17T14:15:50-05:00

Hospital & Healthcare Management January 17, 2022

Understanding the Purpose of Biomedicine2022-01-17T14:15:50-05:00

Better Vaccines, New Treatments And More Tests: Healthcare Companies Reveal Covid Plans

2022-01-15T19:34:55-05:00

Forbes January 14, 2022

Better Vaccines, New Treatments And More Tests: Healthcare Companies Reveal Covid Plans2022-01-15T19:34:55-05:00